$TRNX Wright Medical Group N.V. Insider Trading Week 32/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Wright Medical Group N.V..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Wright Medical Group N.V. in week 32/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 12 2014 | TRNX | Wright Medical Gro ... | CARNEY SEAN | Director | Option Exercise | A | 21.65 | 6,034 | 130,606 | 6,034 | |
Aug 12 2014 | TRNX | Wright Medical Gro ... | CARNEY SEAN | Director | Grant | A | 22.91 | 5,238 | 120,003 | 28,319 | 23.1 K to 28.3 K (+22.69 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | CARNEY SEAN | Director | Grant | A | 0.00 | 2,728 | 0 | 23,081 | 20.4 K to 23.1 K (+13.40 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | CARNEY SEAN | Director | Payment of Exercise | F | 21.73 | 873 | 18,970 | 20,353 | 21.2 K to 20.4 K (-4.11 %) |
Aug 15 2014 | TRNX | Wright Medical Gro ... | Epinette Stephan | VP, Int'l Commercia ... | Sell | S | 22.00 | 2,500 | 55,000 | 35,310 | 37.8 K to 35.3 K (-6.61 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | WEATHERMAN ELIZABETH H | Director | Option Exercise | A | 21.65 | 6,034 | 130,606 | 6,034 | |
Aug 12 2014 | TRNX | Wright Medical Gro ... | WEATHERMAN ELIZABETH H | Director | Grant | A | 22.91 | 1,964 | 44,995 | 18,142 | 16.2 K to 18.1 K (+12.14 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | WEATHERMAN ELIZABETH H | Director | Grant | A | 0.00 | 2,728 | 0 | 16,178 | 13.5 K to 16.2 K (+20.28 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | WEATHERMAN ELIZABETH H | Director | Payment of Exercise | F | 21.73 | 873 | 18,970 | 13,450 | 14.3 K to 13.5 K (-6.10 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | WALLMAN RICHARD F | Director | Option Exercise | A | 21.65 | 6,034 | 130,606 | 6,034 | |
Aug 12 2014 | TRNX | Wright Medical Gro ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 2,728 | 0 | 59,722 | 57 K to 59.7 K (+4.79 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | WALLMAN RICHARD F | Director | Payment of Exercise | F | 21.73 | 873 | 18,970 | 56,994 | 57.9 K to 57 K (-1.51 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Option Exercise | A | 21.65 | 6,034 | 130,606 | 6,034 | |
Aug 12 2014 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 2,728 | 0 | 12,149 | 9.4 K to 12.1 K (+28.96 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Payment of Exercise | F | 21.73 | 873 | 18,970 | 9,421 | 10.3 K to 9.4 K (-8.48 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | Tornier Alain | Director | Option Exercise | A | 21.65 | 6,034 | 130,606 | 6,034 | |
Aug 12 2014 | TRNX | Wright Medical Gro ... | Tornier Alain | Director | Grant | A | 22.91 | 1,746 | 40,001 | 17,338 | 15.6 K to 17.3 K (+11.20 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | Tornier Alain | Director | Grant | A | 0.00 | 2,728 | 0 | 15,592 | 12.9 K to 15.6 K (+21.21 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | Tornier Alain | Director | Payment of Exercise | F | 21.73 | 873 | 18,970 | 12,864 | 13.7 K to 12.9 K (-6.36 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | EMMITT RICHARD B | Director | Option Exercise | A | 21.65 | 6,034 | 130,606 | 6,034 | |
Aug 12 2014 | TRNX | Wright Medical Gro ... | EMMITT RICHARD B | Director | Grant | A | 22.91 | 2,401 | 55,007 | 65,523 | 63.1 K to 65.5 K (+3.80 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | EMMITT RICHARD B | Director | Grant | A | 0.00 | 2,728 | 0 | 63,122 | 60.4 K to 63.1 K (+4.52 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | EMMITT RICHARD B | Director | Payment of Exercise | F | 21.73 | 873 | 18,970 | 60,394 | 61.3 K to 60.4 K (-1.42 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | Rich Terry | Sr VP US Commercial ... | Option Exercise | A | 21.65 | 22,307 | 482,835 | 22,307 | |
Aug 12 2014 | TRNX | Wright Medical Gro ... | Rich Terry | Sr VP US Commercial ... | Grant | A | 0.00 | 10,085 | 0 | 54,947 | 44.9 K to 54.9 K (+22.48 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | van Ummersen Gordon | Sr. VP, Product Del ... | Option Exercise | A | 21.65 | 17,190 | 372,078 | 17,190 | |
Aug 12 2014 | TRNX | Wright Medical Gro ... | van Ummersen Gordon | Sr. VP, Product Del ... | Grant | A | 0.00 | 7,772 | 0 | 43,042 | 35.3 K to 43 K (+22.04 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | Mowry David H | President and CEO | Option Exercise | A | 21.65 | 66,373 | 1,436,644 | 66,373 | |
Aug 12 2014 | TRNX | Wright Medical Gro ... | Mowry David H | President and CEO | Grant | A | 0.00 | 30,009 | 0 | 85,698 | 55.7 K to 85.7 K (+53.89 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | McCormick Shawn | Chief Financial Off ... | Option Exercise | A | 21.65 | 22,051 | 477,294 | 22,051 | |
Aug 12 2014 | TRNX | Wright Medical Gro ... | McCormick Shawn | Chief Financial Off ... | Grant | A | 0.00 | 9,970 | 0 | 50,299 | 40.3 K to 50.3 K (+24.72 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | Morrison Gregory | Global VP, Human Re ... | Option Exercise | A | 21.65 | 18,102 | 391,818 | 18,102 | |
Aug 12 2014 | TRNX | Wright Medical Gro ... | Morrison Gregory | Global VP, Human Re ... | Grant | A | 0.00 | 8,184 | 0 | 52,158 | 44 K to 52.2 K (+18.61 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | Klemz Kevin M | Sr. VP, CLO and Sec ... | Option Exercise | A | 21.65 | 20,085 | 434,740 | 20,085 | |
Aug 12 2014 | TRNX | Wright Medical Gro ... | Klemz Kevin M | Sr. VP, CLO and Sec ... | Grant | A | 0.00 | 9,081 | 0 | 54,547 | 45.5 K to 54.5 K (+19.97 %) |
Aug 12 2014 | TRNX | Wright Medical Gro ... | Epinette Stephan | VP Int'l Commercial ... | Option Exercise | A | 21.65 | 23,723 | 513,484 | 23,723 | |
Aug 12 2014 | TRNX | Wright Medical Gro ... | Epinette Stephan | VP Int'l Commercial ... | Grant | A | 0.00 | 10,726 | 0 | 37,810 | 27.1 K to 37.8 K (+39.60 %) |